93 related articles for article (PubMed ID: 32694116)
21. Up-regulation of stem cell markers by P21-activated kinase 1 contributes to 5-fluorouracil resistance of colorectal cancer.
Huynh N; Shulkes A; Baldwin G; He H
Cancer Biol Ther; 2016 Aug; 17(8):813-23. PubMed ID: 27260988
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of SNX1 predicts poor prognosis and contributes to drug resistance in colorectal cancer.
Bian Z; Feng Y; Xue Y; Hu Y; Wang Q; Zhou L; Liu Z; Zhang J; Yin Y; Gu B; Huang Z
Tumour Biol; 2016 May; 37(5):6619-25. PubMed ID: 26643894
[TBL] [Abstract][Full Text] [Related]
23. Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells.
Shen Y; Tong M; Liang Q; Guo Y; Sun HQ; Zheng W; Ao L; Guo Z; She F
Pharmacogenomics J; 2018 Jan; 18(1):23-28. PubMed ID: 28045128
[TBL] [Abstract][Full Text] [Related]
24. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
[TBL] [Abstract][Full Text] [Related]
25. Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post-chemotherapy tissues.
Tong M; Zheng W; Lu X; Ao L; Li X; Guan Q; Cai H; Li M; Yan H; Guo Y; Chi P; Guo Z
Oncotarget; 2015 Dec; 6(38):41216-27. PubMed ID: 26515599
[TBL] [Abstract][Full Text] [Related]
26. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
[TBL] [Abstract][Full Text] [Related]
27. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.
Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S
J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498
[TBL] [Abstract][Full Text] [Related]
28. The role of microRNAs in 5-FU resistance of colorectal cancer: Possible mechanisms.
Marjaneh RM; Khazaei M; Ferns GA; Avan A; Aghaee-Bakhtiari SH
J Cell Physiol; 2019 Mar; 234(3):2306-2316. PubMed ID: 30191973
[TBL] [Abstract][Full Text] [Related]
29. ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NF‑κB signaling pathway.
Wang Z; Zhao X; Wang W; Liu Y; Li Y; Gao J; Wang C; Zhou M; Liu R; Xu G; Zhou Q
Int J Oncol; 2018 Nov; 53(5):2102-2110. PubMed ID: 30106136
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy-induced
Wang F; Zhao L; Zhang J; Meng Z; Zhou C; Wang G; Liu Y; Li M; Xi J; Niu W; Wang G
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30429233
[TBL] [Abstract][Full Text] [Related]
31. Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells.
Zhang Q; Liu RX; Chan KW; Hu J; Zhang J; Wei L; Tan H; Yang X; Liu H
J Exp Clin Cancer Res; 2019 Jul; 38(1):320. PubMed ID: 31324203
[TBL] [Abstract][Full Text] [Related]
32. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
[TBL] [Abstract][Full Text] [Related]
33. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer.
Nakanishi R; Kitao H; Fujinaka Y; Yamashita N; Iimori M; Tokunaga E; Yamashita N; Morita M; Kakeji Y; Maehara Y
Ann Surg Oncol; 2012 Oct; 19(11):3627-35. PubMed ID: 22526901
[TBL] [Abstract][Full Text] [Related]
34. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive Genetic Search to Clarify the Molecular Mechanism of Drug Resistance Identifies ASCL2-LEF1/TSPAN8 Axis in Colorectal Cancer.
Tanaka T; Kojima K; Yokota K; Tanaka Y; Ooizumi Y; Ishii S; Nishizawa N; Yokoi K; Ushiku H; Kikuchi M; Kojo K; Minatani N; Katoh H; Sato T; Nakamura T; Sawanobori M; Watanabe M; Yamashita K
Ann Surg Oncol; 2019 May; 26(5):1401-1411. PubMed ID: 30706227
[TBL] [Abstract][Full Text] [Related]
36. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
Hu J; Cai G; Xu Y; Cai S
Curr Mol Med; 2016; 16(1):70-82. PubMed ID: 26695693
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
[TBL] [Abstract][Full Text] [Related]
38. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
[TBL] [Abstract][Full Text] [Related]
39. LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p.
Bian Z; Jin L; Zhang J; Yin Y; Quan C; Hu Y; Feng Y; Liu H; Fei B; Mao Y; Zhou L; Qi X; Huang S; Hua D; Xing C; Huang Z
Sci Rep; 2016 Apr; 6():23892. PubMed ID: 27046651
[TBL] [Abstract][Full Text] [Related]
40. Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer.
Kaneko M; Kotake M; Bando H; Yamada T; Takemura H; Minamoto T
BMC Cancer; 2016 Dec; 16(1):945. PubMed ID: 27955637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]